Prem S. Shah - 08 Apr 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Co-President of Retail
Signature
/s/ Prem S. Shah
Issuer symbol
CVS
Transactions as of
08 Apr 2022
Net transactions value
-$918,025
Form type
4
Filing time
12 Apr 2022, 16:51:58 UTC
Previous filing
05 Apr 2022
Next filing
30 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Options Exercise $52,567 +845 +1.8% $62.21 47,428 08 Apr 2022 Direct
transaction CVS Common Stock Sale $88,725 -845 -1.8% $105.00 46,583 08 Apr 2022 Direct F1
transaction CVS Common Stock Options Exercise $171,078 +3,157 +6.8% $54.19 49,740 08 Apr 2022 Direct
transaction CVS Common Stock Sale $331,485 -3,157 -6.3% $105.00 46,583 08 Apr 2022 Direct F1
transaction CVS Common Stock Options Exercise $333,646 +5,719 +12% $58.34 52,302 08 Apr 2022 Direct
transaction CVS Common Stock Sale $600,495 -5,719 -11% $105.00 46,583 08 Apr 2022 Direct F1
transaction CVS Common Stock Options Exercise $304,853 +4,103 +8.8% $74.30 50,686 08 Apr 2022 Direct
transaction CVS Common Stock Sale $430,815 -4,103 -8.1% $105.00 46,583 08 Apr 2022 Direct F1
transaction CVS Common Stock Sale $328,650 -3,130 -6.7% $105.00 43,453 08 Apr 2022 Direct F1
holding CVS Common Stock (pep) 4,413 08 Apr 2022 Direct F2
holding CVS Common Stock (restricted) 16,522 08 Apr 2022 Direct
holding CVS ESOP Common Stock 4,539 08 Apr 2022 Direct
holding CVS Common Stock (restricted) 2,829 08 Apr 2022 Direct F3
holding CVS Stock Unit (deferred) 6,634 08 Apr 2022 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -845 -50% $0.000000 846 08 Apr 2022 Common Stock 845 $62.21 Direct F5
transaction CVS Stock Option Options Exercise $0 -3,157 -25% $0.000000 9,469 08 Apr 2022 Common Stock 3,157 $54.19 Direct F6
transaction CVS Stock Option Options Exercise $0 -5,719 -17% $0.000000 28,596 08 Apr 2022 Common Stock 5,719 $58.34 Direct F7
transaction CVS Stock Option Options Exercise $0 -4,103 -12% $0.000000 28,723 08 Apr 2022 Common Stock 4,103 $74.30 Direct F8
holding CVS Stock Option 2,935 08 Apr 2022 Common Stock 2,935 $104.82 Direct F9
holding CVS Stock Option 26,580 08 Apr 2022 Common Stock 26,580 $75.24 Direct F10
holding CVS Phantom Stock Credits 11,259 08 Apr 2022 Common Stock 11,259 $1.00 Direct F11, F12
holding CVS Stock Option 41,580 08 Apr 2022 Common Stock 41,580 $101.09 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Consists of Matching RSUs awarded pursuant to Issuer's Partnership Equity Program, a sub-plan under its ICP, and dividend equivalents on the Matching RSUs. Restrictions lapse on the RSUs on 08/31/2023.
F3 Consists of RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan under its 2017 ICP. Restrictions on the 2018 grant lapse in three equal installments commencing on 02/26/2022; restrictions on the 2020 grant lapse in two equal installments commencing on 2/28/22.
F4 Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
F5 Option becomes exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
F6 Option becomes exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised.
F7 Option becomes exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
F8 Option becomes exercisable in three equal installments commencing 04/01/2022.
F9 Option becomes exercisable in four equal installments commencing 04/01/2017.
F10 Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023.
F11 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F12 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F13 Option becomes exercisable in four equal installments, commencing 4/1/2023.